ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
8.24
-0.22 (-2.60%)
At close: May 22, 2026, 4:00 PM EDT
8.29
+0.05 (0.61%)
After-hours: May 22, 2026, 6:47 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
ADMA BioManufacturing Revenue
493.03M493.00M415.81M
ADMA BioManufacturing Revenue Growth
0.01%18.57%66.50%
Plasma Collection Centers Revenue
-17.03M10.51M
Plasma Collection Centers Revenue Growth
-62.11%26.05%
License Revenue
143.00K143.00K143.00K
Revenue (Other)
16.70M--
Revenue (Total)
509.86M510.17M426.45M
Revenue (Total) Growth
-0.06%19.63%65.16%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
506.76M504.07M410.15M
United States Revenue Growth
0.53%22.90%67.49%
International Revenue
-6.11M16.31M
International Revenue Growth
--62.55%22.29%
Revenue (Other)
3.10M--
Revenue (Total)
509.86M510.17M426.45M
Revenue (Total) Growth
-0.06%19.63%65.16%

EBT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
ADMA BioManufacturing Income Before Taxes
252.17M230.65M173.14M
ADMA BioManufacturing Income Before Taxes Growth
9.33%33.22%266.30%
Plasma Collection Centers Income Before Taxes
2.43M-5.36M-5.04M
Updated May 6, 2026. Data Source: Fiscal.ai.